14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for CORT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 28.76 2.37 %
R2 28.46 1.31 %
R1 28.27 0.657 %
Current price: 28.09
Support S1 27.68 -1.46 %
S2 27.49 -2.12 %
S3 27.20 -3.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 28.09
Support S1 24.15 -14.03%
S2 23.00 -18.12%
S3 22.30 -20.61%

CORT Predictions History

6 years ago
JuanC Villegas predicted that CORT for 2017-07-20 is going $12.99 (0.85%)

6 years ago
JS predicted that CORT for 2017-07-20 is going $12.74 (-1.09%)

6 years ago
JuanC Villegas predicted that CORT for 2017-07-19 is going $12.57 (1.29%)

6 years ago
JS predicted that CORT for 2017-07-19 is going $12.37 (-0.32%)

6 years ago
JuanC Villegas predicted that CORT for 2017-07-14 is going $12.53 (1.46%)

6 years ago
JS predicted that CORT for 2017-07-14 is going $12.53 (1.46%)

7 years ago
Abdu predicted that CORT for 2016-11-14 is going $9.89 (1.54%)

7 years ago
PumpTheseNumbers predicted that CORT for 2016-09-23 is going $6.38 (-1.69%)

7 years ago
JS predicted that CORT for 2016-09-23 is going $6.43 (-0.92%)

Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT